Purpose: Although associated with an overall favorable survival rate, the heterogeneity of
non-muscle invasive bladder cancer (NMIBC) affects patients' rates of recurrence and …

Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …

In Europe, an estimated 151 297 new cases of bladder cancer were diagnosed in 2012, with
an age-standardised incidence rate (per 100000 persons) of 17.7 for males and 3.5 for …

Purpose High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-
invasive bladder cancer, with highly variable prognosis, poorly understood risk factors, and …

Bladder cancer (BC) ranks as the sixth most prevalent cancer in the world, with a steady rise
in its incidence and prevalence, and is accompanied by a high morbidity and mortality. BC is …

Abstract High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-
invasive bladder cancer with unpredictable outcome and poorly understood risk factors …

Context This review focuses on the most widely used risk stratification and prediction tools
for non–muscle-invasive bladder cancer (NMIBC). Objective To assess the clinical use and …

Objective The aim of this study was to summarize and analyze the current evidence
regarding the prognostic and predictive value of preoperative neutrophil-to-lymphocyte ratio …

Context Radiomics is a field of science that aims to develop improved methods of medical
image analysis by extracting a large number of quantitative features. New data have …

Non—muscle-invasive bladder cancer (NMIBC) is a heterogeneous subclassification of
urothelial carcinoma with significant variation in individual risk of recurrence and …